vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and Wheels Up Experience Inc. (UP). Click either name above to swap in a different company.
Wheels Up Experience Inc. is the larger business by last-quarter revenue ($183.8M vs $180.9M, roughly 1.0× AVANOS MEDICAL, INC.). AVANOS MEDICAL, INC. runs the higher net margin — -0.7% vs -15.7%, a 15.0% gap on every dollar of revenue. On growth, AVANOS MEDICAL, INC. posted the faster year-over-year revenue change (0.7% vs -10.2%). AVANOS MEDICAL, INC. produced more free cash flow last quarter ($21.3M vs $-58.3M). Over the past eight quarters, AVANOS MEDICAL, INC.'s revenue compounded faster (4.4% CAGR vs -3.4%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Wheels Up is a provider of "on demand" private aviation in the United States and one of the largest private aviation companies in the world. It was founded in 2013 by Kenny Dichter, using a membership/on-demand business model. Wheels Up members can book private aircraft from the company fleet and third-party operators using a mobile application.
AVNS vs UP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $183.8M |
| Net Profit | $-1.3M | $-28.9M |
| Gross Margin | 47.5% | 14.3% |
| Operating Margin | 1.4% | -0.9% |
| Net Margin | -0.7% | -15.7% |
| Revenue YoY | 0.7% | -10.2% |
| Net Profit YoY | 99.7% | 67.0% |
| EPS (diluted) | $-0.02 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $180.9M | $183.8M | ||
| Q3 25 | $177.8M | $185.5M | ||
| Q2 25 | $175.0M | $189.6M | ||
| Q1 25 | $167.5M | $177.5M | ||
| Q4 24 | $179.6M | $204.8M | ||
| Q3 24 | $170.4M | $193.9M | ||
| Q2 24 | $171.7M | $196.3M | ||
| Q1 24 | $166.1M | $197.1M |
| Q4 25 | $-1.3M | $-28.9M | ||
| Q3 25 | $-1.4M | $-83.7M | ||
| Q2 25 | $-76.8M | $-82.3M | ||
| Q1 25 | $6.6M | $-99.3M | ||
| Q4 24 | $-397.3M | $-87.5M | ||
| Q3 24 | $4.3M | $-57.7M | ||
| Q2 24 | $1.8M | $-97.0M | ||
| Q1 24 | $-900.0K | $-97.4M |
| Q4 25 | 47.5% | 14.3% | ||
| Q3 25 | 48.4% | 6.8% | ||
| Q2 25 | 52.6% | 8.3% | ||
| Q1 25 | 53.6% | 10.8% | ||
| Q4 24 | 54.6% | 13.9% | ||
| Q3 24 | 54.5% | 13.9% | ||
| Q2 24 | 55.7% | 2.3% | ||
| Q1 24 | 57.1% | -0.6% |
| Q4 25 | 1.4% | -0.9% | ||
| Q3 25 | 0.1% | -33.1% | ||
| Q2 25 | -42.6% | -31.4% | ||
| Q1 25 | 6.1% | -45.5% | ||
| Q4 24 | -233.0% | -26.0% | ||
| Q3 24 | 7.0% | -21.6% | ||
| Q2 24 | 3.7% | -40.3% | ||
| Q1 24 | 2.4% | -42.9% |
| Q4 25 | -0.7% | -15.7% | ||
| Q3 25 | -0.8% | -45.1% | ||
| Q2 25 | -43.9% | -43.4% | ||
| Q1 25 | 3.9% | -55.9% | ||
| Q4 24 | -221.2% | -42.7% | ||
| Q3 24 | 2.5% | -29.8% | ||
| Q2 24 | 1.0% | -49.4% | ||
| Q1 24 | -0.5% | -49.4% |
| Q4 25 | $-0.02 | $-0.04 | ||
| Q3 25 | $-0.03 | $-0.12 | ||
| Q2 25 | $-1.66 | $-0.12 | ||
| Q1 25 | $0.14 | $-0.14 | ||
| Q4 24 | $-8.64 | $-0.13 | ||
| Q3 24 | $0.09 | $-0.08 | ||
| Q2 24 | $0.04 | $-0.14 | ||
| Q1 24 | $-0.02 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $133.9M |
| Total DebtLower is stronger | $90.3M | $671.3M |
| Stockholders' EquityBook value | $778.2M | $-392.1M |
| Total Assets | $1.1B | $968.8M |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.8M | $133.9M | ||
| Q3 25 | $70.5M | $125.3M | ||
| Q2 25 | $90.3M | $107.0M | ||
| Q1 25 | $97.0M | $171.8M | ||
| Q4 24 | $107.7M | $216.4M | ||
| Q3 24 | $89.0M | $115.9M | ||
| Q2 24 | $92.2M | $141.5M | ||
| Q1 24 | $75.8M | $180.9M |
| Q4 25 | $90.3M | $671.3M | ||
| Q3 25 | $93.4M | $766.5M | ||
| Q2 25 | $95.7M | $770.5M | ||
| Q1 25 | $98.0M | $765.8M | ||
| Q4 24 | $125.3M | $761.3M | ||
| Q3 24 | $152.6M | $596.9M | ||
| Q2 24 | $164.9M | $597.4M | ||
| Q1 24 | $167.2M | $603.2M |
| Q4 25 | $778.2M | $-392.1M | ||
| Q3 25 | $778.0M | $-374.5M | ||
| Q2 25 | $776.3M | $-347.8M | ||
| Q1 25 | $839.4M | $-288.1M | ||
| Q4 24 | $828.5M | $-202.1M | ||
| Q3 24 | $1.2B | $-117.7M | ||
| Q2 24 | $1.2B | $-72.2M | ||
| Q1 24 | $1.2B | $936.0K |
| Q4 25 | $1.1B | $968.8M | ||
| Q3 25 | $1.1B | $973.0M | ||
| Q2 25 | $1.0B | $1.0B | ||
| Q1 25 | $1.1B | $1.1B | ||
| Q4 24 | $1.2B | $1.2B | ||
| Q3 24 | $1.7B | $1.0B | ||
| Q2 24 | $1.7B | $1.1B | ||
| Q1 24 | $1.7B | $1.2B |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — | ||
| Q1 24 | 0.14× | 644.43× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | $-18.4M |
| Free Cash FlowOCF − Capex | $21.3M | $-58.3M |
| FCF MarginFCF / Revenue | 11.8% | -31.7% |
| Capex IntensityCapex / Revenue | 3.8% | 21.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | $-259.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $28.2M | $-18.4M | ||
| Q3 25 | $14.0M | $-37.1M | ||
| Q2 25 | $6.8M | $-62.9M | ||
| Q1 25 | $25.7M | $-47.9M | ||
| Q4 24 | $57.9M | $37.9M | ||
| Q3 24 | $23.0M | $-16.9M | ||
| Q2 24 | $27.8M | $-25.2M | ||
| Q1 24 | $-8.0M | $-73.8M |
| Q4 25 | $21.3M | $-58.3M | ||
| Q3 25 | $7.0M | $-60.4M | ||
| Q2 25 | $-4.2M | $-78.6M | ||
| Q1 25 | $19.0M | $-62.6M | ||
| Q4 24 | $53.1M | $-70.2M | ||
| Q3 24 | $20.0M | $-21.9M | ||
| Q2 24 | $21.9M | $-30.8M | ||
| Q1 24 | $-12.1M | $-77.8M |
| Q4 25 | 11.8% | -31.7% | ||
| Q3 25 | 3.9% | -32.6% | ||
| Q2 25 | -2.4% | -41.5% | ||
| Q1 25 | 11.3% | -35.3% | ||
| Q4 24 | 29.6% | -34.3% | ||
| Q3 24 | 11.7% | -11.3% | ||
| Q2 24 | 12.8% | -15.7% | ||
| Q1 24 | -7.3% | -39.5% |
| Q4 25 | 3.8% | 21.7% | ||
| Q3 25 | 3.9% | 12.5% | ||
| Q2 25 | 6.3% | 8.3% | ||
| Q1 25 | 4.0% | 8.3% | ||
| Q4 24 | 2.7% | 52.8% | ||
| Q3 24 | 1.8% | 2.6% | ||
| Q2 24 | 3.4% | 2.9% | ||
| Q1 24 | 2.5% | 2.0% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.89× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 5.35× | — | ||
| Q2 24 | 15.44× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
UP
Segment breakdown not available.
